These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17482419)

  • 1. [Prostate cancer screening in the general population: the drawbacks are certain but the benefits are hypothetical].
    Aupérin A; Laplanche A; Hill C
    Presse Med; 2007; 36(7-8):1045-53. PubMed ID: 17482419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostate cancer and care. When male intimacy is put to the test...].
    Héron M
    Soins; 2007 Mar; (713):31. PubMed ID: 17419565
    [No Abstract]   [Full Text] [Related]  

  • 3. [We must screen prostate cancer in the general population].
    Coulange C
    Presse Med; 2007; 36(7-8):1043-4. PubMed ID: 17482420
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.
    Chou R; Croswell JM; Dana T; Bougatsos C; Blazina I; Fu R; Gleitsmann K; Koenig HC; Lam C; Maltz A; Rugge JB; Lin K
    Ann Intern Med; 2011 Dec; 155(11):762-71. PubMed ID: 21984740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erectile dysfunction and urinary incontinence after prostate cancer treatment.
    Mirza M; Griebling TL; Kazer MW
    Semin Oncol Nurs; 2011 Nov; 27(4):278-89. PubMed ID: 22018407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The devil is in the details.
    Eastham JA; Scardino PT
    Eur Urol; 2011 May; 59(5):708-9; discussion 710-1. PubMed ID: 21315503
    [No Abstract]   [Full Text] [Related]  

  • 8. The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trial.
    Carlsson S; Aus G; Bergdahl S; Khatami A; Lodding P; Stranne J; Hugosson J
    Eur J Cancer; 2011 Mar; 47(4):545-53. PubMed ID: 21087857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Japanese guideline for prostate cancer screening.
    Hamashima C; Nakayama T; Sagawa M; Saito H; Sobue T
    Jpn J Clin Oncol; 2009 Jun; 39(6):339-51. PubMed ID: 19346535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
    Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
    Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].
    Villers A; Grosclaude P; Haillot O; Abbou CC; Richard F; Boccon-Gibod L
    Prog Urol; 1997 Jun; 7(3):508-15. PubMed ID: 9273082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic radical prostatectomy: a less invasive approach.
    Paré J
    Can Oper Room Nurs J; 2006 Sep; 24(3):31, 33, 36-7. PubMed ID: 17044265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: 8. Urinary incontinence and erectile dysfunction.
    Hassouna MM; Heaton JP
    CMAJ; 1999 Jan; 160(1):78-86. PubMed ID: 9934350
    [No Abstract]   [Full Text] [Related]  

  • 14. [Early detection in prostate cancer and shared decision making].
    Junod AF
    Praxis (Bern 1994); 2005 Sep; 94(39):1525-9. PubMed ID: 16223112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A guideline to clinical utility of prostate specific antigen.
    Farhat WA; Habbal AA; Khauli RB
    Saudi Med J; 2000 Mar; 21(3):223-7. PubMed ID: 11533789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
    Hedgepeth RC; Labo J; Zhang L; Wood DP
    J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancers of the prostate, penis, and testicles: epidemiology, prevention, and treatment.
    Stotts RC
    Nurs Clin North Am; 2004 Jun; 39(2):327-40. PubMed ID: 15159183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer?
    Sun M; Abdollah F; Hansen J; Trinh QD; Bianchi M; Tian Z; Briganti A; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    J Sex Med; 2012 Nov; 9(11):2961-9. PubMed ID: 22672479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The great prostate cancer debate.
    Garnick MB
    Sci Am; 2012 Feb; 306(2):38-43. PubMed ID: 22295676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.